Read more
1:57 PM · 9 February 2021

Tilray soared in pre-market on medical cannabis agreement

-
-
Open account Download free app

Tilray (TLRY.US), a pharmaceutical and cannabis company, gained roughly 20% in pre-market trading as the firm announced it has entered into an agreement with Grow Pharma - the leader in supplying unlicensed cannabis medicines in the UK. Under the agreement, Grow Pharma will distribute Tilray’s medical cannabis products across the United Kingdom. Tilray’s stock price skyrocketed in recent weeks, which might be associated with hopes that Joe Biden could potentially introduce federal marijuana legalisation. 

Tilray (TLRY.US) gained in recent weeks as Biden is expected to support medical cannabis legalisation. Stock price climbed above key area at $22.45 and is expected to open almost 20% higher today. Source: xStation5

11 February 2026, 3:17 PM

Palo Alto acquires CyberArk. A new leader in cybersecurity!

11 February 2026, 2:44 PM

US OPEN: Blowout Payrolls Signal Slower Path for Rate Cuts?

11 February 2026, 1:15 PM

Market wrap: Oil gains amid US - Iran tensions 📈 European indices muted before US NFP report

11 February 2026, 8:30 AM

Economic calendar: NFP data and US oil inventory report 💡

Join over 2 000 000 XTB Group Clients from around the world
The financial instruments we offer, especially CFDs, can be highly risky. Fractional Shares (FS) is an acquired from XTB fiduciary right to fractional parts of stocks and ETFs. FS are not a separate financial instrument. The limited corporate rights are associated with FS.
This page was not created for investors residing in Brazil. This brokerage is not authorized by the Comissão de Valores Mobiliários (CVM) or the Brazilian Central Bank (BCB). The content of this page should not be characterized as an investment offer in Brazil or for investors residing in that country.
Losses can exceed deposits